Stock Price
1,330.40
Daily Change
3.70 0.28%
Monthly
-13.09%
Yearly
-9.59%
Q1 Forecast
1,299.11

Cipla reported INR7.96B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
aTyr Pharma USD 6.15M 11.07M Sep/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 41.52B 53.85B Sep/2025